Unoprostone Terminated Phase 3 Trials for Retinitis Pigmentosa (RP) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01786395Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis Pigmentosa